Investment Strategy

We back highly-experienced management teams to lead fast-growing, revenue-generating healthcare companies.

We are healthcare specialists: this dynamic, resilient and growing sector is our passion and our only business.

  • US$20 to $200M in revenues
  • EBITDA-positive or soon to be
  • Revenue growth drives returns
  • Minority or majority positions
Tell Me More

We invest broadly across the healthcare spectrum

...

Pharmaceuticals

~$900 billion in global sales, driven by aging demographics, increasing insurance coverage and innovation

...

MedTech

~$430 billion in global sales, driven by focus on healthcare outcomes and costs

...

Tech-Enabled Services

$350+ billion in global sales as the largest segment of healthcare industry evolving to deliver quality rather than quantity of care

Global macro trends support healthcare investing

Change Creates Opportunities in
Developed Markets

  • Healthcare is one of the largest segments of the economy at an average of 19.7% of GDP

  • Aging population, increasing disease burden, growing middle class, and continued adoption of innovative tech and therapies

  • Knowledge and new technology drive innovation that continues to give rise to new products and companies

All content © 2023
Legal Disclaimer | Privacy Notice

Powered by ITVibes